恒瑞醫(yī)藥：子公司阿得貝利單抗注射液、注射用SHR-A1921藥物臨床試驗獲得藥物臨床試驗批準

array(1) { [484362]=> array(2) { [2]=> array(3) { [0]=> string(12) "臨床試驗" [1]=> string(12) "恒瑞醫(yī)藥" [2]=> string(12) "單抗概念" } [4]=> array(1) { [0]=> string(19) "同花順7x24快訊" } } }